H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway

Oncotarget
Marion CortierAli Bettaieb

Abstract

High doses of the organic nitrate glyceryl trinitrate (GTN), a nitric oxide (NO) donor, are known to trigger apoptosis in human cancer cells. Here, we show that such a cytotoxic effect can be obtained with subtoxic concentrations of GTN when combined with H89, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulphonamide.2HCl. This synergistic effect requires the generation of reactive oxygen species (ROS) from H89 and NO from GTN treatment that causes cGMP production and PKG activation. Furthermore, the GTN/H89 synergy was attenuated by inhibition of P2-purinergic receptors with suramin and competition with ATP/UDP. By down-regulating genes with antisense oligonucleotides, P2-purinergic receptors P2X3, P2Y1, and P2Y6 were found to have a role in creating this cytotoxic effect. Thus, H89 likely acts as an ATP mimetic synergizing with GTN to trigger apoptosis in aggressive cancer cells.

References

Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Oct 14, 1994·Biochemical and Biophysical Research Communications·M Schweizer, C Richter
Jan 1, 1994·Annual Review of Physiology·S H Francis, J D Corbin
Jul 1, 1996·Archives of Biochemistry and Biophysics·R WelterC A Yu
Nov 29, 1996·The Journal of Biological Chemistry·M MuñizA Velasco
Jun 23, 1998·The Journal of Biological Chemistry·T P MiskoD Salvemini
Jun 29, 2000·Annual Review of Biochemistry·A J Shaywitz, M E Greenberg
Oct 26, 2000·Trends in Biochemical Sciences·S Raha, B H Robinson
Dec 26, 2001·Journal of the National Cancer Institute·N E MatthewsC H Graham
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jost LeemhuisDieter K Meyer
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zhiqiang ChenJonathan S Stamler
Nov 21, 2002·Cellular and Molecular Life Sciences : CMLS·P V Vignais
Feb 27, 2003·Clinical Pharmacokinetics·Satoru Hashimoto, Atsuko Kobayashi
Oct 17, 2003·The Journal of Physiology·Julio F Turrens
Nov 1, 2003·Science·Ted M Dawson, Valina L Dawson
Jan 22, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Robson Coutinho-SilvaGeoffrey Burnstock
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiroyasu YasudaHidetada Sasaki
Jul 11, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Benjamin BonavidaHermes Garbán
Aug 29, 2006·Biochemical Pharmacology·Liaman K MamedovaKenneth A Jacobson
Dec 7, 2007·Journal of Cell Science·Sonja BuvinicAlfonso González
Sep 23, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Liaman K MamedovaKenneth A Jacobson
Jan 20, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Michael S Wolin
Mar 1, 2011·Gastroenterology·Lissbeth Leon-BollotteAli Bettaieb

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
flow cytometry
ELISA
antisense oligonucleotides
transfection
protein assay
electrophoresis
PCR

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Deutsche medizinische Wochenschrift
B Hinz, H Schröder
The Journal of Pharmacology and Experimental Therapeutics
P NeedlemanS Lang
The Journal of Pharmacy and Pharmacology
D STEPHENSON, J F HUMPHREYS-JONES
© 2021 Meta ULC. All rights reserved